Business Wire - November 12, 2009
Through the agreement, Centro de Genomas will provide the advanced technical support and customer care that ABL TherapyEdge customers have come to appreciate and value highly. Centro de Genomas will offer customers expanded training and support via workshops and in-office training.
ABL and Centro de Genomas will work closely to develop strategic partnerships in Brazil. The combined alliance will seek to find a national or a regional corporate Diagnostic distributor for ABL's products line.
In accordance with its full commitment to support research, which include free medical tools and exchange of knowledge for the benefit of humanity, ABL has proposed Centro de Genomas to be in contact with any researcher, university and non-profit institution in Brazil to offer them royalty free sublicense rights on ABL US patents (Barry et al 6.081.786, 6.188.988 and their foreign equivalents including the ones prosecuted in Brazil).
"We're extremely pleased about this new partnership. We believe Brazilian infectious diseases specialists and patients will see the benefits of an integrated IT solution such as TherapyEdge. We have now TherapyEdge customized for the Brazilian market which should ease its widespread use," said Dr Chalom Sayada, CEO of ABL.
"ABL is the ideal company to partner with us. The electronic medical records market and online services is growing rapidly and fulfills important needs for integrated disease management in complex diseases such as HIV and viral hepatitis. It is completing our offer for advanced healthcare technologies," said Mrs Cinthia Vilhena, CEO of Centro de Genomas.
"The TherapyEdge ViroScore platform will offer Brazilian clinicians, virologists and epidemiologists with a suite of comprehensive tools to support their clinical routine but also their research from therapeutics to genomics," said Dr Ricardo Sobhie Diaz, Medical Director of Centro de Genomas.
More information about ABL at www.ablsa.com and Centro de Genomas at www.centrodegenomas.com.br
Contacts
Advanced Biological Laboratories (ABL), S.A.
Phone: +352 2638 8921
Fax: +352 2638 8938
Email: chalom@ablsa.com
Attention: Chalom B. Sayada (CEO)
or
Centro de Genomas
Phone: +55 11 5079 9593
Fax: +55 11 5585 9242
Email: cvilhena@centrodegenomas.com.br
Attention: Dra Cintia Vilhena
091112
BW091113
Copyright © 2009 - Business Wire. All rights reserved. Reproduced with permission. Reproduction of this article (other than one copy for personal reference) must be cleared through the Business Wire, Permissions Desk, Business Wire, 1185 Avenue of the Americas, 3rd Floor, New York, NY 10036; Tel: (212) 575-8822; FAX: (212) 575-1854. http://www.businesswire.com.
AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Broadway Cares/Equity Fights AIDS, Elton John AIDS Foundation, the National Library of Medicine, Pacific Life Foundation and donations from users like you.
Always watch for outdated information. This article first appeared in 2009. This material is designed to support, not replace, the relationship that exists between you and your doctor.
AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.
Copyright ©1980, 2009. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .